Axon Enterprise, Inc $AXON Shares Acquired by Freestone Capital Holdings LLC

Freestone Capital Holdings LLC increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 7.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,136 shares of the biotechnology company’s stock after purchasing an additional 220 shares during the period. Freestone Capital Holdings LLC’s holdings in Axon Enterprise were worth $2,596,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in AXON. Brighton Jones LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at about $480,000. DAVENPORT & Co LLC boosted its holdings in Axon Enterprise by 5.1% in the 1st quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company’s stock worth $494,000 after acquiring an additional 46 shares during the period. Teacher Retirement System of Texas grew its position in Axon Enterprise by 1,475.1% in the first quarter. Teacher Retirement System of Texas now owns 10,585 shares of the biotechnology company’s stock valued at $5,567,000 after acquiring an additional 9,913 shares in the last quarter. Strategic Blueprint LLC grew its position in Axon Enterprise by 2.7% in the first quarter. Strategic Blueprint LLC now owns 941 shares of the biotechnology company’s stock valued at $495,000 after acquiring an additional 25 shares in the last quarter. Finally, TD Private Client Wealth LLC raised its stake in shares of Axon Enterprise by 7.8% during the first quarter. TD Private Client Wealth LLC now owns 1,123 shares of the biotechnology company’s stock valued at $591,000 after purchasing an additional 81 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CFO Brittany Bagley sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer directly owned 93,592 shares in the company, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Hadi Partovi purchased 1,358 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The shares were purchased at an average cost of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the transaction, the director owned 237,938 shares in the company, valued at approximately $176,074,120. This represents a 0.57% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have sold 59,932 shares of company stock worth $45,115,616. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Price Performance

AXON opened at $724.10 on Tuesday. The company has a market capitalization of $56.84 billion, a P/E ratio of 178.79, a PEG ratio of 29.49 and a beta of 1.41. The company has a 50-day moving average of $730.27 and a 200-day moving average of $735.04. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 1-year low of $424.99 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s revenue for the quarter was up 32.6% compared to the same quarter last year. During the same period last year, the firm earned $1.20 earnings per share. Equities analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Ratings Changes

AXON has been the subject of several analyst reports. UBS Group restated a “neutral” rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. Raymond James Financial restated an “outperform” rating and set a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. Finally, Bank of America increased their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $841.64.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.